Secular trends in antibiotic use among neonates: 2001-2008

Pediatric Infectious Disease Journal

Volumn 30, Issue 5, 2011, Pages 365-370

  Zingg, Walter ^a   Pfister, Riccardo ^a   Posfay Barbe, Klara M ^a   Huttner, Benedikt ^a   Touveneau, Sylvie ^a   Pittet, Didier ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

antibiotic use; bloodstream infection; clinical sepsis; neonates; surveillance

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG USE; HEALTH CARE POLICY; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN; NEWBORN CARE; PRIORITY JOURNAL; SEPSIS; STAPHYLOCOCCUS INFECTION;

EID: 79954822334     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31820243d3     Document Type: Article

References (47)

1. Davey P, Brown E, Fenelon L, et al. Systematic review of antimicrobial drug prescribing in hospitals. Emerg Infect Dis. 2006;12:211-216.
2. Shlaes DM, Gerding DN, John JF Jr, et al. Society for Healthcare Epide-miology of America and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997; 25:584-599. (Pubitemid 127774277)
3. Dellit TH, Owens RC, McGowan JE, et al. Infectious diseases Society of America and the Society for Healthcare Epidemiology of America guide-lines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-177. (Pubitemid 46084814)
4. Girouard S, Levine G, Goodrich K, et al. Infection control programs at children's hospitals: a description ofstructures and processes. Am J Infect Control. 2001;29:145-151. (Pubitemid 32507078)
5. Lawton RM, Fridkin SK, Gaynes RP, et al. Practices to improve antimi-crobial use at 47 US hospitals: the status ofthe 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/Infectious Diseases Society of America. Infect Control Hosp Epidemiol. 2000;21:256-259.
6. Sunenshine RH, Liedtke LA, Jernigan DB, et al. Role of infectious diseases consultants in management of antimicrobial use in hospitals. Clin Infect Dis. 2004;38:934-938. (Pubitemid 38457199)
7. Harbarth S, Harris AD, Carmeli Y, et al. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. Clin Infect Dis. 2001;33:1462-1468. (Pubitemid 34246137)
8. Pepin J, Saheb N, Coulombe MA, et al. Emergence offluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during anepidemic inQuebec. Clin Infect Dis. 2005;41:1254-1260. (Pubitemid 41532667)
9. Patel SJ, Oshodi A, Prasad P, et al. Antibiotic use in neonatal intensive care units and adherence with centers for disease control and prevention 12 step campaign to prevent antimicrobial resistance. Pediatr Infect Dis J. 2009; 28:1047-1051.
10. Muller AA, Mauny F, Bertin M, et al. Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital. Clin Infect Dis. 2003;36:971-978. (Pubitemid 36513280)
11. Asensio A, Oliver A, Gonzalez-Diego P, et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis. 2000;30:55-60. (Pubitemid 30067062)
12. Zaoutis T, Dawid S, Kim JO. Multidrug-resistant organisms in general pediatrics. Pediatr Ann. 2002;31:313-320. (Pubitemid 34808846)
13. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a random-ized trial. JAMA. 2003;290:2588-2598. (Pubitemid 37443289)
14. Harbarth S, Samore MH, Lichtenberg D, et al. Prolonged antibiotic pro-phylaxis after cardiovascular surgery and its effect on surgical site infec-tions and antimicrobial resistance. Circulation. 2000;101:2916-2921. (Pubitemid 30415881)
15. Carling P, Fung T, Killion A, et al. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol. 2003;24:699-706. (Pubitemid 37221343)
16. Climo MW, Israel DS, Wong ES, et al. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med. 1998;128:989-995. (Pubitemid 28275175)
17. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(suppl 2):S82-S89. (Pubitemid 43054219)
18. Lesprit P, Brun-Buisson C. Hospital antibiotic stewardship. Curr Opin Infect Dis. 2008;21:344-349.
19. Metjian TA, Prasad PA, Kogon A, et al. Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J. 2008;27:106-111.
20. Fischer JE, Ramser M, Fanconi S. Use of antibiotics in pediatric intensive care and potential savings. Intensive Care Med. 2000;26:959-966. (Pubitemid 30616051)
21. Pakyz AL, Gurgle HE, Ibrahim OM, et al. Trends in antibacterial use in hospitalized pediatric patients in United States academic health centers. Infect Control Hosp Epidemiol. 2009;30:600-603.
22. Pessoa-Silva CL, Hugonnet S, Pfister R, et al. Reduction of health care associated infection risk in neonates by successful hand hygiene promotion Pediatrics. 2007;120:e382-e390. (Pubitemid 47219489)
23. Lambert P, Major L, Saint-Onge E, et al. L'intégration de la Planification des Soins et de la Mesure de la Charge de Travail au Service des Démarches Scientifiques du Soignant et du Gestionnaire: la Méthode PRN. Montréal, Canada: Hôpitaux du Québec; 1990:189-194.
24. Pakyz AL, MacDougall C, Oinonen M, et al. Trends in antibacterial use in US academic health centers: 2002 to 2006. Arch Intern Med. 2008;168: 2254-2260.
25. Herigon JC, Hersh AL, Gerber JS, et al. Antibiotic management of Staph-ylococcus aureus infections in US children's hospitals, 1999-2008. Pedi-atrics. 2010;125:e1294-e1300.
26. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-140.
27. Baier RJ, Bocchini JA Jr, Brown EG. Selective use of vancomycin to prevent coagulase-negative staphylococcal nosocomial bacteremia in high risk very low birth weight infants. Pediatr Infect Dis J. 1998;17:179-183. (Pubitemid 28146056)
28. Cooke RW, Nycyk JA, Okuonghuae H, et al. Low-dose vancomycin prophylaxis reduces coagulase-negative staphylococcal bacteremia in very low birthweight infants. J Hosp Infect. 1997;37:297-303. (Pubitemid 28025085)
29. Lodha A, Furlan AD, Whyte H, et al. Prophylactic antibiotics in the prevention ofcatheter-associated bloodstream bacterial infection in preterm neonates: a systematic review. JPerinatol. 2008;28:526-533.
30. Manzoni P, Stolfi I, Pugni L, et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med. 2007;356: 2483-2495. (Pubitemid 46919774)
31. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-332. (Pubitemid 351763841)
32. Centers for Disease Control and Prevention. Fact sheet: 12-steps to prevent antimicrobial resistance among hospitalized children. Available at: www. cdc.gov/drugresistance/healthcare/children/12steps-children.htm. Accessed July 21, 2010.
33. Rubin LG, Sanchez PJ, Siegel J, et al. Evaluation and treatment ofneonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics. 2002;110:e42-e48.
34. Mermel LA, Maki DG. Detection ofbacteremia in adults: consequences of culturing an inadequate volume ofblood. Ann Intern Med. 1993;119:270-272. (Pubitemid 23319882)
35. Connell TG, Rele M, Cowley D, et al. How reliable is a negative blood culture result? Volume ofblood submitted for culture in routine practice in a children's hospital. Pediatrics. 2007;119:891-896. (Pubitemid 46715658)
36. Stocker M, Fontana M, El Helou S, et al. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology. 2010; 97:165-174.
37. Franz AR, Steinbach G, Kron M, et al. Interleukin-8: a valuable tool to restrict antibiotic therapy in newborn infants. Acta Paediatr. 2001;90:1025-1032. (Pubitemid 32912378)
38. Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network (NHSN) report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control. 2008;36:609-626.
39. Bradley JS, Nelson JD. Nelson's Pocket Book of Pediatric Antimicrobial Therapy. 17th ed. Elk Grove Village, IL: American Academy ofPediatrics; 2009.
40. Brady PW, Conway PH, Goudie A. Duration of inpatient intravenous antibiotic therapy and treatment failure in infants hospitalized with urinary tract infections. Pediatrics. 2010;126:196-203.
41. Huang YC, Chou YH, Su LH, et al. Methicillin-resistant Staphylococcus aureus colonization and its association with infection among infants hos-pitalized in neonatal intensive care units. Pediatrics. 2006;118:469-474.
42. Gerber SI, Jones RC, Scott MV, et al. Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal inten-sive care unit: a consensus statement. Infect Control Hosp Epidemiol. 2006;27:139-145. (Pubitemid 43384760)
43. Ko KS, Park S, Peck KR, et al. Molecular characterization of methicillin-resistant Staphylococcus aureus spread by neonates transferred from pri-mary obstetrics clinics to a tertiary care hospital in Korea. Infect Control Hosp Epidemiol. 2006;27:593-597. (Pubitemid 44023395)
44. Zingg W, Posfay-Barbe KM, Pittet D. Healthcare-associated infections in neonates. Curr Opin Infect Dis. 2008;21:228-234. (Pubitemid 351620376)
45. Shakil S, Ali SZ, Akram M, et al. Risk factors for extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. J Trop Pediatr. 2010;56:90-96.
46. Jain A, Mondal R. Prevalence & antimicrobial resistance pattern of ex-tended spectrum beta-lactamase producing Klebsiella spp isolated from cases ofneonatal septicaemia. Indian J Med Res. 2007;125:89-94. (Pubitemid 46403683)
47. Heininger U, Datta F, Gervaix A, et al. Prevalence of nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) in children: a multicenter cross-sectional study. Pediatr Infect Dis J. 2007;26:544-546. (Pubitemid 46847320)